amsacrine has been researched along with Atypical Chronic Myeloid Leukemia in 1 studies
Amsacrine: An aminoacridine derivative that intercalates into DNA and is used as an antineoplastic agent.
amsacrine : A sulfonamide that is N-phenylmethanesulfonamide substituted by a methoxy group at position 3 and an acridin-9-ylamino group at position 4. It exhibits antineoplastic activity.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Four had an antecedent chronic phase of chronic myelogenous leukemia and 15 presented with ALL." | 1.28 | Philadelphia chromosome (Ph1)-positive acute lymphoblastic leukemia (ALL) is resistant to effective therapy for Ph1-negative ALL. ( Ahmed, T; Arlin, ZA; Feldman, EJ; Liebowitz, D; Shapiro, LR; Wilmot, PL, 1989) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Arlin, ZA | 1 |
| Feldman, EJ | 1 |
| Ahmed, T | 1 |
| Liebowitz, D | 1 |
| Shapiro, LR | 1 |
| Wilmot, PL | 1 |
1 other study available for amsacrine and Atypical Chronic Myeloid Leukemia
| Article | Year |
|---|---|
Philadelphia chromosome (Ph1)-positive acute lymphoblastic leukemia (ALL) is resistant to effective therapy for Ph1-negative ALL.
Topics: Adolescent; Adult; Amsacrine; Antineoplastic Combined Chemotherapy Protocols; Cytarabine; Drug Evalu | 1989 |